Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Total Liabilities 2020–2025
Annovis Bio, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Annovis Bio, Inc. total liabilities as of December 31, 2025: 4.2M, a 8.39% decrease year-over-year.
- Annovis Bio, Inc. total liabilities for 2025 were 4.2M, a 8.39% decrease from 2024.
- Annovis Bio, Inc. total liabilities for 2024 were 4.6M, a 74.29% decrease from 2023.
- Annovis Bio, Inc. total liabilities for 2023 were 18.0M, a 133.28% increase from 2022.
- Annovis Bio, Inc. total liabilities for 2022 were 7.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Annovis Bio, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $5 |
| 2023 | $18 |
| 2022 | $8 |
| 2021 | $2 |
| 2020 | $1 |
Annovis Bio, Inc. Total Liabilities — FAQ
Annovis Bio, Inc. (ANVS) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANVS's total liabilities history?
The chart and table above show Annovis Bio, Inc.'s total liabilities by year and by quarter, including the growth rate.